Navigation Links
Bunge Reports Fourth Quarter Net Income of $245 Million
Date:2/7/2008

8 - 18 - 8 - 0.07

Litigation

settlement - 6 - 6 - 4 - 0.03

Total $(106) $- $(106) $- $(66) $(4) $(0.51) $(0.03)

(1) Impairment and restructuring pretax charges in the quarter ended

December 31, 2007 consisted of $25 million in the agribusiness

segment, $29 million in the edible oil products segment, and $13

million in the milling products segment. Impairment and restructuring

pretax charges in the year ended December 31, 2007 consisted of $30

million in the agribusiness segment, $35 million in the edible oil

products segment and $13 million in the milling products segment. The

impairment and restructuring charges for the quarter and year ended

December 31, 2007 were recorded in cost of goods sold, other than $11

million of the edible oil products segment total, which was recorded

in selling general and administrative expenses. Impairment and

restructuring charges in the year ended December 31, 2006 consisted

of $20 million in the agribusiness segment and $2 million in the

edible oil products segment, which were recorded in cost of goods

sold, and $2 million in the fertilizer segment, which was recorded in

selling general and administrative expenses.

(2) Value-added-tax provision of $50 million in the quarter and year ended

December 31, 2007 in the fertilizer segment resulted from a recent

change in tax laws in several Brazilian states that will take effect

in 2008, which will make the recoverability of these taxes uncertain.

(3) Gain on sale of investments of $22 million recorded in other income

(expense)-net in the quarter and year ended December 31, 2007 resulted

from a sale of investment securities.

CONSOLIDATED STATEMENTS OF IN
'/>"/>

SOURCE Bunge Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
2. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
3. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
4. Recent Research Reports and Near-Term Corporate Events
5. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
6. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
7. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
8. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
9. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
10. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
11. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
Post Your Comments:
*Name:
*Comment:
*Email: